340B Advocacy Alliance Bulletin

The U.S. District Court of Maine today granted a preliminary injunction blocking implementation of the Department of Health and Human Services 340B Rebate Model Pilot Program.
A Bloomberg article published today (linked here and text below) discusses how the Department of Health and Human Services plans to “survey safety-net hospitals on the amount they pay for prescription drugs, following up on an effort to reduce the hospitals’ Medicare drug reimbursement during the…
The Health Resources and Services Administration posted on its website that it had approved eight drug company plans for participation in the 340B Rebate Model Pilot Program with a start date of Jan. 1, 2026.
The Senate Committee on Health, Education, Labor and Pensions today held a hearing discussing the 340B Drug Pricing Program and its growth and impacts on patients.
In 2022, tax-exempt hospitals participating in the 340B Drug Pricing Program provided nearly $100 billion in total benefits to their communities, according to a new AHA report.